Drug Discovery

#Clinical research #Clinical trial #Drug discovery #Phase I trial

New episode of DDW Highlights podcast

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  It was recently Clinical Trials Day and DDW have reported on the launch of a number… Read More

#News

Basel, Switzerland
#Events #Future Labs Live #Lab automation #Lab of the future #Lab technology

Countdown begins to Future Labs Live 

The countdown for Future Labs Live has begun. The event is set to take place in a week’s time, covering topics across the whole lab ecosystem, from facilities, to training and development, to automation and digital transformation. With over 200 speakers confirmed and 2000… Read More

#Editor's Choice #News

#Clinical research #Clinical trial #Drug discovery #Phase I trial

This week in drug discovery (15-19 May)

News round-up for 15-19 May by DDW Digital Content Editor Diana Spencer. It’s Clinical Trials Day tomorrow and this week we have reported on the launch of a number of new Phase I trials. In-human studies have been initiated to test treatments for Parkinson’s disease, radioactive… Read More

#News

Medical research
#Drug discovery #Kynos Therapeutics #Phase I trial

First-in-human Phase I study of KMO inhibitor launches in UK

Scotland-based Kynos Therapeutics has launched a first-in-human Phase I trial of its kynurenine 3-monooxygenase (KMO) inhibitor KNS366. The study aims to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple doses of KNS366 in healthy adult participants. The study is being conducted at a… Read More

#News

Protein degradation
#Drug development #Drug discovery #Guide #PROTAC #Protein degradation

Build effective protein degraders – answer these four questions

A new Guide is now available for download from NanoTemper. The development of a successful PROTAC candidate requires overcoming challenges at each stage of development. Read this guide to learn about common roadblocks, technologies to overcome them, and how to ensure you’re on the right track to building an efficient… Read More

#News

#Drug development #Drug discovery #Guide #PROTAC #Protein degradation

How to build an effective protein degrader

The development of a successful PROTAC candidate requires overcoming challenges at each stage of development. Read this guide to learn about common roadblocks, technologies to overcome them, and how to ensure you’re on the right track to building an efficient protein degrader. Download this guide to learn about: The most… Read More

#Intelligence #Resources

#Clinical research #Clinical trials #Drug discovery #Precision medicine

New podcast on how precision medicine will transform clinical trials

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this latest episode, DDW’s Megan Thomas is in conversation with… Read More

#News

New appointment
#Appointment #Drug discovery #Life sciences #New appointment

12 key industry appointments

A round-up of the top senior appointments in the drug discovery sector over the last month. Renos Savva, Head of Innovation, Discovery Park Savva’s previous experience includes co-founding Domainex, recognised by the Financial Times in 2018 as the ‘fastest-growing drug discovery contract research… Read More

#News

#Collaboration #Drug development #Drug discovery #License agreement #Mergers and acquisitions

This week in drug discovery (8-12 May)

News round-up for 8-12 May by DDW Digital Content Editor Diana Spencer. Inspired by the relaunch of PerkinElmer’s Life Science and Diagnostics business this week as Revvity, my top five news story this week all relate to new drug discovery business developments. See below for the… Read More

#News

Chemistry
#Bioorthogonal chemistry #Click chemistry #Drug discovery #Molecular Biology

The Nobel Prize winning power of click chemistry

Listen to this article on the DDW Podcast: José Mejía Oneto, PhD, Founder and CEO at Shasqi, discusses the potential of chemistry to engineer biology to improve the effectiveness of human therapeutics and revolutionise the treatment of disease. What if we could control… Read More

#Exclusive Content

#Drug development #Drug discovery #Genetics / genomics #Mass spectrometry / NMR

The path to improved safety of gene-based products

Listen to this article on the DDW Podcast: Kerstin Pohl, Senior Global Marketing Manager, Gene Therapy & Nucleic Acid at SCIEX, looks at the application of liquid chromatography-mass spectrometry for analysing host cell proteins. Gene-based therapeutics and vaccines hold immense potential for more… Read More

#Exclusive Content

Cutting the red ribbon
#Drug discovery #Omics #PerkinElmer #Preclinical development #Revvity

PerkinElmer’s Life Science and Diagnostics business becomes Revvity

PerkinElmer’s Life Science and Diagnostics business has revealed its new name and branding. Revvity has now officially launched as a science-based solutions company. Based on two words, ‘revolutionise’ (rev) and ‘vita’ (vit) meaning ‘life’ in Latin, Revvity will provide reagents, consumables, assays, instruments and software to customers… Read More

#Business & Investment #News

#Animal models #Animal testing #Assays #Drug development #Drug discovery #Mouse models

Accelerating NDA filing through faster carcinogenicity assessment

Dr Megan MacBride and Dr Caroline Horizny Mitchell, Taconic, examine recent changes to animal testing in drug design. Drug discovery and development is an arduous process that can cost upwards of $2.6 billion and take over 10 years. While the discovery phase – which includes target… Read More

#Exclusive Content

AI brain
#AI / data analytics / healthtech / informatics #Drug discovery #Funding #MultiOmic Health #Precision medicine #Seed funding #Start-ups

AI platform focuses on precision medicines for metabolic syndromes

AI drug discovery company MultiOmic Health has closed a £5 million ($6.2 million) seed funding extension round to build a precision therapeutics discovery platform for metabolic syndrome-related medical conditions. The round was led by London-based Hoxton Ventures, with participation from Ada Ventures, MMC Ventures and Verve… Read More

#News #Start-up Zone

#Drug development #Drug discovery #Immuno-oncology #Immunomodulators #Immunotherapy #Oncology

Podcast: Keep up to date with DDW Highlights

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  DDW’s Diana Spencer has selected five stand-out news headlines this week, which all relate to immunotherapy… Read More

#News

#Drug development #Drug discovery #Immuno-oncology #Immunomodulators #Immunotherapy #Oncology

This week in drug discovery (1-5 May)

News round-up for 1-5 May by DDW Digital Content Editor Diana Spencer. My five stand-out news headlines this week all relate to immunotherapy or immunomodulatory therapies for cancer, particularly advances in our understanding of how other factors in the body, i.e., vitamin D levels and the… Read More

#News